Highlights for &alpha;-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma

doi:10.3748/wjg.v18.i48.7242

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5819)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

489

HTML

3373

Figures (1-2)

160

Tables (1-4)

186

Sum=4208

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1106

Download

504

Sum=1610

Dec 28, 2012 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2012; 18(48): 7242-7250
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7242

Full Size Figure Download Figure

Figure 2 Forest plots representing the correlation between α-fetoprotein response and radiological response. A: Risks of no radiological response; B: Risks of disease control failure. AFP: α-fetoprotein; RR: Relative risk.

Citation: Xu XS, Qu K, Liu C, Zhang YL, Liu J, Song YZ, Zhang P, Liu SN, Chang HL. Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma. World J Gastroenterol 2012; 18(48): 7242-7250
URL: https://www.wjgnet.com/1007-9327/full/v18/i48/7242.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i48.7242